Table 1. Summary of patient and tumor features.
| Characteristics | Number of patients (%) | Local recurrence (%) | No recurrence (%) | P value |
|---|---|---|---|---|
| Sex | 0.370 | |||
| Male | 34 (75.6) | 11 (32.4) | 23 (67.6) | |
| Female | 11 (24.4) | 2 (18.2) | 9 (81.8) | |
| Stages | 0.370 | |||
| IA | 35 (77.8) | 12 (34.3) | 23 (65.7) | |
| IB | 10 (22.2) | 1 (10.0) | 9 (90.0) | |
| Tumor size | 0.630 | |||
| T1a | 20 (44.4) | 5 (25.0) | 15 (75.0) | |
| T1b | 16 (35.6) | 6 (37.5) | 10 (62.5) | |
| T2a | 9 (20.0) | 2 (22.2) | 7 (77.8) | |
| BED | 0.720 | |||
| <100 Gy | 29 (64.4) | 11 (37.9) | 18 (62.1) | |
| >100 Gy | 16 (35.6) | 2 (12.5) | 14 (87.5) | |
| Margins | 0.048 | |||
| Spiculated | 28 (62.2) | 5 (17.9) | 23 (82.1) | |
| Polylobate | 7 (15.6) | 5 (71.4) | 2 (28.6) | |
| Smooth | 4 (8.9) | 1 (25.0) | 3 (75.0) | |
| Irregular | 6 (13.3) | 2 (33.3) | 4 (66.7) |
BED, biologically effective dose.